Apollo Medical Holdings Inc
F:3AM

Watchlist Manager
Apollo Medical Holdings Inc Logo
Apollo Medical Holdings Inc
F:3AM
Watchlist
Price: 37.2 EUR 1.64% Market Closed
Market Cap: €1.8B

Wall St Price Targets

3AM Price Targets Summary
Apollo Medical Holdings Inc

Wall Street analysts forecast 3AM stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 3AM is 24.58 EUR with a low forecast of 21.69 EUR and a high forecast of 27.5 EUR.

Lowest Forecast
Price Target
21.69 EUR
42% Downside
Average Forecast
Price Target
24.58 EUR
34% Downside
Highest Forecast
Price Target
27.5 EUR
26% Downside
Apollo Medical Holdings Inc Competitors:
Price Targets
SMMT
Summit Therapeutics Inc
97% Upside
OGI
OrganiGram Holdings Inc
108% Upside

Revenue
Forecast

42% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
42% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

Over the last 4 years, the compound annual growth rate for Revenue has been 42%. The projected CAGR for the next 3 years is 15%.

Gross Profit
Forecast

18% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
18% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Over the last 4 years, the compound annual growth rate for Gross Profit has been 18%. The projected CAGR for the next 3 years is 16%.

Operating Income
Forecast

0% / Year
Past Growth
37% / Year
Estimated Growth
Estimates Accuracy
-14%
Average Miss
0% / Year
Past Growth
37% / Year
Estimated Growth
Estimates Accuracy
-14%
Average Miss

Over the last 4 years, the compound annual growth rate for Operating Income has been 0%. The projected CAGR for the next 3 years is 37%.

Pre-Tax Income
Forecast

-16% / Year
Past Growth
62% / Year
Estimated Growth
Estimates Accuracy
-19%
Average Miss
-16% / Year
Past Growth
62% / Year
Estimated Growth
Estimates Accuracy
-19%
Average Miss

Over the last 4 years, the compound annual growth rate for Pre-Tax Income has been -16%. The projected CAGR for the next 3 years is 62%.

Net Income
Forecast

-24% / Year
Past Growth
68% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
-24% / Year
Past Growth
68% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Over the last 4 years, the compound annual growth rate for Net Income has been -24%. The projected CAGR for the next 3 years is 68%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 3AM's stock price target?
Price Target
24.58 EUR

According to Wall Street analysts, the average 1-year price target for 3AM is 24.58 EUR with a low forecast of 21.69 EUR and a high forecast of 27.5 EUR.

What is the Revenue forecast for Apollo Medical Holdings Inc?
Projected CAGR
15%

Over the last 4 years, the compound annual growth rate for Revenue has been 42%. The projected CAGR for the next 3 years is 15%.

What is the Gross Profit forecast for Apollo Medical Holdings Inc?
Projected CAGR
16%

Over the last 4 years, the compound annual growth rate for Gross Profit has been 18%. The projected CAGR for the next 3 years is 16%.

What is the Operating Income forecast for Apollo Medical Holdings Inc?
Projected CAGR
37%

Over the last 4 years, the compound annual growth rate for Operating Income has been 0%. The projected CAGR for the next 3 years is 37%.

What is the Pre-Tax Income forecast for Apollo Medical Holdings Inc?
Projected CAGR
62%

Over the last 4 years, the compound annual growth rate for Pre-Tax Income has been -16%. The projected CAGR for the next 3 years is 62%.

What is the Net Income forecast for Apollo Medical Holdings Inc?
Projected CAGR
68%

Over the last 4 years, the compound annual growth rate for Net Income has been -24%. The projected CAGR for the next 3 years is 68%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett